Annual Current Liabilities
$7.55 M
+$2.94 M+63.88%
31 December 2023
Summary:
Fennec Pharmaceuticals annual total current liabilities is currently $7.55 million, with the most recent change of +$2.94 million (+63.88%) on 31 December 2023. During the last 3 years, it has risen by +$5.21 million (+221.82%). FENC annual current liabilities is now -30.81% below its all-time high of $10.92 million, reached on 31 December 2010.FENC Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$7.43 M
-$314.00 K-4.05%
30 September 2024
Summary:
Fennec Pharmaceuticals quarterly total current liabilities is currently $7.43 million, with the most recent change of -$314.00 thousand (-4.05%) on 30 September 2024. Over the past year, it has increased by +$3.52 million (+90.01%). FENC quarterly current liabilities is now -32.43% below its all-time high of $11.00 million, reached on 31 March 2013.FENC Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FENC Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +63.9% | +90.0% |
| 3 y3 years | +221.8% | +269.2% |
| 5 y5 years | +361.4% | +721.5% |
FENC Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +356.6% | -24.4% | +349.5% |
| 5 y | 5 years | at high | +361.4% | -24.4% | +776.8% |
| alltime | all time | -30.8% | +1778.9% | -32.4% | +2329.7% |
Fennec Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $7.43 M(-4.1%) |
| June 2024 | - | $7.75 M(-21.2%) |
| Mar 2024 | - | $9.84 M(+30.2%) |
| Dec 2023 | $7.55 M(+63.9%) | $7.55 M(+93.0%) |
| Sept 2023 | - | $3.91 M(+3.6%) |
| June 2023 | - | $3.78 M(-6.0%) |
| Mar 2023 | - | $4.02 M(-12.8%) |
| Dec 2022 | $4.61 M(+178.7%) | $4.61 M(+57.5%) |
| Sept 2022 | - | $2.93 M(-3.6%) |
| June 2022 | - | $3.04 M(+42.2%) |
| Mar 2022 | - | $2.14 M(+29.1%) |
| Dec 2021 | $1.65 M(-29.5%) | $1.65 M(-17.9%) |
| Sept 2021 | - | $2.01 M(+137.5%) |
| June 2021 | - | $848.00 K(-70.7%) |
| Mar 2021 | - | $2.89 M(+23.2%) |
| Dec 2020 | $2.35 M(+3.3%) | $2.35 M(-18.6%) |
| Sept 2020 | - | $2.88 M(-9.6%) |
| June 2020 | - | $3.19 M(+67.3%) |
| Mar 2020 | - | $1.91 M(-16.0%) |
| Dec 2019 | $2.27 M(+38.7%) | $2.27 M(+150.9%) |
| Sept 2019 | - | $905.00 K(-33.1%) |
| June 2019 | - | $1.35 M(-6.8%) |
| Mar 2019 | - | $1.45 M(-11.4%) |
| Dec 2018 | $1.64 M(-0.4%) | $1.64 M(-21.1%) |
| Sept 2018 | - | $2.08 M(+145.1%) |
| June 2018 | - | $847.00 K(-27.8%) |
| Mar 2018 | - | $1.17 M(-28.6%) |
| Dec 2017 | $1.64 M(+309.0%) | $1.64 M(+59.6%) |
| Sept 2017 | - | $1.03 M(+77.6%) |
| June 2017 | - | $580.00 K(+35.8%) |
| Mar 2017 | - | $427.00 K(+6.2%) |
| Dec 2016 | $402.00 K(-14.6%) | $402.00 K(+11.7%) |
| Sept 2016 | - | $360.00 K(-20.2%) |
| June 2016 | - | $451.00 K(+30.7%) |
| Mar 2016 | - | $345.00 K(-26.8%) |
| Dec 2015 | $471.00 K(-73.2%) | $471.00 K(+9.3%) |
| Sept 2015 | - | $431.00 K(-43.2%) |
| June 2015 | - | $759.00 K(-32.4%) |
| Mar 2015 | - | $1.12 M(-36.2%) |
| Dec 2014 | $1.76 M(-45.2%) | $1.76 M(-54.9%) |
| Sept 2014 | - | $3.90 M(-31.6%) |
| June 2014 | - | $5.71 M(-0.4%) |
| Mar 2014 | - | $5.73 M(+78.6%) |
| Dec 2013 | $3.21 M(-56.2%) | $3.21 M(-32.7%) |
| Sept 2013 | - | $4.77 M(+37.8%) |
| June 2013 | - | $3.46 M(-68.6%) |
| Mar 2013 | - | $11.00 M(+50.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $7.32 M(+33.8%) | $7.32 M(+344.8%) |
| Sept 2012 | - | $1.65 M(+5.9%) |
| June 2012 | - | $1.55 M(-28.1%) |
| Mar 2012 | - | $2.16 M(-60.5%) |
| Dec 2011 | $5.47 M(-49.9%) | $5.47 M(-45.0%) |
| Sept 2011 | - | $9.94 M(+32.3%) |
| June 2011 | - | $7.51 M(-5.2%) |
| Mar 2011 | - | $7.92 M(-27.4%) |
| Dec 2010 | $10.92 M(+2499.3%) | $10.92 M(+3467.6%) |
| Sept 2010 | - | $306.00 K(-17.3%) |
| June 2010 | - | $370.00 K(-12.5%) |
| Mar 2010 | - | $423.00 K(+0.7%) |
| Dec 2009 | $420.00 K(-82.7%) | $420.00 K(+24.6%) |
| Sept 2009 | - | $337.00 K(-54.8%) |
| June 2009 | - | $745.00 K(-53.2%) |
| Mar 2009 | - | $1.59 M(-34.4%) |
| Dec 2008 | $2.43 M(+1.2%) | $2.43 M(-16.3%) |
| Sept 2008 | - | $2.90 M(+20.8%) |
| June 2008 | - | $2.40 M(+0.6%) |
| Mar 2008 | - | $2.39 M(-0.5%) |
| Dec 2007 | $2.40 M(-48.8%) | $2.40 M(+13.9%) |
| Sept 2007 | - | $2.11 M(+42.2%) |
| June 2007 | - | $1.48 M(-27.7%) |
| Mar 2007 | - | $2.05 M(-56.3%) |
| Dec 2006 | $4.70 M(+76.2%) | $4.70 M(+37.8%) |
| Sept 2006 | - | $3.41 M(+44.7%) |
| June 2006 | - | $2.35 M(-2.6%) |
| Mar 2006 | - | $2.42 M(-9.3%) |
| Dec 2005 | $2.66 M(+80.6%) | $2.66 M(+27.2%) |
| Sept 2005 | - | $2.09 M(-22.5%) |
| June 2005 | - | $2.70 M(+70.8%) |
| Mar 2005 | - | $1.58 M(+14.9%) |
| Sept 2004 | - | $1.38 M(-6.7%) |
| June 2004 | $1.47 M(+35.6%) | $1.47 M(+52.7%) |
| Mar 2004 | - | $966.00 K(-20.6%) |
| Dec 2003 | - | $1.22 M(+41.9%) |
| Sept 2003 | - | $857.30 K(-21.2%) |
| June 2003 | $1.09 M(+56.5%) | $1.09 M(+57.4%) |
| Mar 2003 | - | $690.90 K(-22.3%) |
| Dec 2002 | - | $888.80 K(-7.4%) |
| Sept 2002 | - | $960.20 K(+38.2%) |
| June 2002 | $694.90 K(+32.3%) | $694.90 K(+34.1%) |
| Mar 2002 | - | $518.30 K(+12.9%) |
| Dec 2001 | - | $458.90 K(+0.1%) |
| Sept 2001 | - | $458.30 K(-12.8%) |
| June 2001 | $525.30 K(+9.6%) | $525.30 K(+18.3%) |
| Dec 2000 | - | $444.00 K |
| June 2000 | $479.50 K | - |
FAQ
- What is Fennec Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Fennec Pharmaceuticals?
- What is Fennec Pharmaceuticals annual current liabilities year-on-year change?
- What is Fennec Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Fennec Pharmaceuticals?
- What is Fennec Pharmaceuticals quarterly current liabilities year-on-year change?
What is Fennec Pharmaceuticals annual total current liabilities?
The current annual current liabilities of FENC is $7.55 M
What is the all time high annual current liabilities for Fennec Pharmaceuticals?
Fennec Pharmaceuticals all-time high annual total current liabilities is $10.92 M
What is Fennec Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, FENC annual total current liabilities has changed by +$2.94 M (+63.88%)
What is Fennec Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of FENC is $7.43 M
What is the all time high quarterly current liabilities for Fennec Pharmaceuticals?
Fennec Pharmaceuticals all-time high quarterly total current liabilities is $11.00 M
What is Fennec Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, FENC quarterly total current liabilities has changed by +$3.52 M (+90.01%)